ALNY · Alnylam Pharmaceuticals, Inc
271.77
USDUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
US$35.88B
PE
0.00
EV/EBITDA
N/A
DIV Yield
0%
Payout Ratio
0%
MQV Rating
2Strong
As at 24/07/2026 04:00:00 PM
Price Chart
Description
- All-Companies
- All-Consensus
- Consensus Cheap
- HALO 500
- HALO All
- HALO Balance Sheet
- HALO Capital Efficiency
- HALO Earnings Momentum
- Hammer Bullish
- Hammer Bullish (Realtime)
- Near Support
Key Fundamentals
EPS 3 yr Growth
-69.70%
EBITDA Margin
-5.30%
Operating Cashflow
-$8m
Free Cash Flow Return
-0.30%
ROIC
-11.10%
Interest Coverage
-0.80
Quick Ratio
2.70
Performance
52 weeks range
Low 262.21 - 495.55
Trade Value (12mth)
US$118,004,445.00
1 week
-5.09%
1 month
-8.61%
YTD
-32.84%
1 year
-18.07%
All time high
495.55
Additional Data
Shares Outstanding (Fully Diluted)
129m
HALO Sector
Healthcare
Next Company Report Date
18-Feb-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
Mqv
Strong
Garp
Very Weak
Mqv Small
Neutral
Momentum
Price
Weak
Earnings
Very Strong
Growth
Earnings
Very Weak
Dividends
Very Weak
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Valuation
Value
Consensus
Yield
News & Announcements
| Date | Event |
28 May 26EDG | |
28 May 26EDG | |
30 April 26EDG | |
30 April 26EDG | |
30 April 26EDG |
